Results 181 to 190 of about 849,020 (309)

First‐line serplulimab plus chemotherapy in extensive‐stage small‐cell lung cancer: Updated results and biomarker analysis from the ASTRUM‐005 randomized clinical trial

open access: yesCancer Communications, EarlyView.
Abstract Background The ASTRUM‐005 study previously demonstrated a significant overall survival (OS) benefit with serplulimab (a programmed death 1 inhibitor) plus chemotherapy versus chemotherapy alone in previously untreated extensive‐stage small‐cell lung cancer (ES‐SCLC).
Ying Cheng   +32 more
wiley   +1 more source

Models for providing improved care in residential care homes: a thematic literature review [PDF]

open access: yes
This Annotated Bibliography is one output from a review of the available research evidence to support improved care in residential care homes as the needs of older people intensify. Key findings The review identified extremely little published evidence
Clay, Diane   +4 more
core  

Treatment With Phosphodiesterase 5 Inhibitors and Long‐Term Outcomes in Patients Undergoing Coronary Angiography and Cardiac Catheterization

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background The effects of phosphodiesterase 5 (PDE5) inhibitors on the incidence of long‐term outcomes in patients with cardiovascular disease are not well understood. Objective: We studied the association between PDE5 inhibitor therapy and the incidence of adverse cardiovascular major adverse cardiovascular events (MACE) in patients ...
Sumon Roy   +5 more
wiley   +1 more source

Dental Needs of Nursing Home Patients

open access: green, 1964
Edward C. Maloof   +3 more
openalex   +2 more sources

A Case Series of Valve‐in‐Valve Transcatheter Aortic Valve Replacement in Stentless Bioprosthetic Valves Using Self‐Expanding Platform With Minimalist Approach

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Valve‐in‐valve (ViV) Transcatheter aortic valve replacement (TAVR) has emerged as a valid treatment option in symptomatic patients with failed aortic bioprosthetic valves, most especially in those with intermediate, high or prohibitive risk of surgery. Due to the unique design of stentless bioprosthetic valves with absence of visible posts and
Adeogo Akinwale Olusan   +3 more
wiley   +1 more source

An Euroheart‐Based Percutaneous Coronary Intervention Registry in Vietnam: Design, Rationale, and Preliminary Results

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background As a cardiac interventional procedure, percutaneous coronary intervention (PCI) is increasingly becoming the most widely adopted across the globe. With increasing implementation in practice, the use of PCI registries to evaluate safety and effectiveness has grown internationally.
Vu Hoang Vu   +6 more
wiley   +1 more source

POS-554 HEMODIALYSIS: CASE SERIES OF SIGNIFICANT THROMBOCYTOPENIA ASSOCIATED WITH DIALYZER CARTRIDGE SYSTEM

open access: yesKidney International Reports, 2021
H.H. Abdelwahab   +5 more
doaj  

Transcatheter Aortic Valve Implantation in a Ross Procedure Patient With Severe Autograft Regurgitation: A Case Report

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Surgical aortic valve replacement (AVR) is the standard treatment for symptomatic severe neo‐aortic regurgitation in Ross patients. The only previous report of a transcatheter aortic valve implantation (TAVI) in a Ross patient required valve‐in‐valve rescue. Thus, this is the first uncomplicated TAVI procedure in a Ross patient.
Anindya Mukherjee   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy